Brief: Abvc Biopharma Receives US Certificate Of PDC-1421 For The Treatment Of Major Depressive Disorder
04/05/2023 13:39
May 4 (Reuters) - ABVC Biopharma Inc ABVC.O :
* ABVC BIOPHARMA RECEIVES US PATENT CERTIFICATE OF PDC-1421
FOR
THE TREATMENT OF MAJOR DEPRESSIVE DISORDER
Source text for Eikon: ID:nGNXbW6DdF
Further company coverage: ABVC.O
Recent news on ABVC Biopharma
See all newsBrief: ABVC Biopharma Says Biokey Share Distribution Rescheduled For August 21
NASDAQ RESUMED AT 09:05 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 04:43 PM
Brief: ABVC Biopharma - Quarterly Period Ended September, 2025 Financial Statements Should Not Be Relied Upon